According to the lawsuit, defendants throughout the Class Period provided investors with material information concerning Centene’s expected revenue guidance and adjusted diluted earnings per share (“EPS”) for the 2025 fiscal year. Defendants’ statements included, among other things, confidence in Centene’s enrollment and morbidity rates, as well as strong retention rates in Centene’s Medicare business. Defendants provided these overwhelmingly positive statements to investors while simultaneously disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Centene’s enrollment and morbidity rates.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Attorney Advertising. Prior results do not guarantee a similar outcome.
